SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950124-01-504079
Filing Date
2001-11-14
Accepted
2001-11-14 00:00:00
Documents
6
Period of Report
2001-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR QUARTER ENDED SEPTEMBER 30, 2001 c66107e10-q.txt 10-Q 63506
3 AMENDMENT TO SUBLICENSE AND DEVELOPMENT AGREEMENT c66107ex10-32.txt EX-10.32 32703
4 LOAN AND SECURITY AGREEMENT c66107ex10-33.txt EX-10.33 36227
5 PROMISSORY NOTE DATED SEPTEMBER 29, 2001 c66107ex10-34.txt EX-10.34 16322
6 NOTE PURCHASE AGREEMENT c66107ex10-35.txt EX-10.35 13376
7 PROMISSORY NOTE DATED AUGUST 14, 2001 c66107ex10-36.txt EX-10.36 14351
  Complete submission text file 0000950124-01-504079.txt   178770
Mailing Address 425 WOODSMILL RD ST LOUIS MO 63017
Business Address 425 WOODSMILL RD ST LOUIS MO 63017 3145799899
SHEFFIELD PHARMACEUTICALS INC (Filer) CIK: 0000894158 (see all company filings)

IRS No.: 133808303 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12584 | Film No.: 1791071
SIC: 2834 Pharmaceutical Preparations